| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/30/2003 | EP1331272A1 Novel glucose dehydrogenase and process for producing the dehydrogenase |
| 07/30/2003 | EP1331269A1 Novel protein, process for producing the same and use thereof |
| 07/30/2003 | EP1331266A1 Cells producing antibody compositions |
| 07/30/2003 | EP1331265A2 density enhanced protein tyrosine phosphatases |
| 07/30/2003 | EP1331227A1 62113, A human acyl-CoA dehydrogenase family member and uses therefor |
| 07/30/2003 | EP1331008A1 Process for the preparation of amylase inhibitor |
| 07/30/2003 | EP1330552A1 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 07/30/2003 | EP1330540A1 A method for immobilizing molecules with physiological activity |
| 07/30/2003 | EP1330537A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 07/30/2003 | EP1330535A2 Kini-3 motor protein and methods for its use |
| 07/30/2003 | EP1330530A2 Herbicide-tolerant plants through bypassing metabolic pathway |
| 07/30/2003 | EP1330529A2 Galactosyltransferase homolog, znssp11 |
| 07/30/2003 | EP1330528A2 Regulation of human serine-threonine protein kinase |
| 07/30/2003 | EP1330526A2 Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family |
| 07/30/2003 | EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330513A1 Recombinant zymomonas mobilis with improved xylose utilization |
| 07/30/2003 | EP1330262A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 07/30/2003 | EP1330166A1 Food grade transglutaminase inhibitor and uses thereof |
| 07/30/2003 | EP1080112B1 Method for separating and/or isolating plasma proteins by annularchromatography |
| 07/30/2003 | EP0834559B1 Process for producing l-lysine by fermentation |
| 07/30/2003 | EP0832198B1 Oxygen activatable formulations for disinfection or sterilization |
| 07/30/2003 | EP0545958B2 A process for hydrolyzing hemicellulose by enzymes produced by trichoderma reesei |
| 07/30/2003 | CN1433477A Method of achieving persistent transgene expression |
| 07/30/2003 | CN1433473A Modification of polysaccharide containing materials |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433467A Modified alpha-1, 2-fucosyl transferase gene and process for producing alpha-1, 2-fucosyl transferase and fucose-containing sugar chain |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1116104C Method capable of scale preserving bioactivity matter by drying |
| 07/29/2003 | US6600094 Recombinant plant expression vector comprising isolated cDNA nucleotide sequence encoding farnesyl pyrophosphate synthase (FPS) derived from seedlings of sunflower (Helianthus annus) |
| 07/29/2003 | US6600091 Nucleotide sequences coding polypeptide for use in enhancing fruit and grain yield of food crops and shelf life of ornamentals |
| 07/29/2003 | US6600089 Carotenoid biosynthesis enzymes |
| 07/29/2003 | US6600029 Expression cassette for use as tools in the transfer of preferential nucleotide sequences into cells |
| 07/29/2003 | US6600021 Enzyme inhibitor for use in the preparation of dough and baked goods |
| 07/29/2003 | US6600020 Protein for use in the treatment of tumor and skin disorders in mammals; protein for use in veterinary medicine |
| 07/29/2003 | US6600019 Polypeptides and nucleic acids encoding same |
| 07/29/2003 | US6599919 Administering reversible competitive inhibitor of enzyme in an amount effective to enhance activity of enzyme in cell |
| 07/29/2003 | US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants |
| 07/29/2003 | US6599880 Analog further comprises an amino acid substitution; for treating gram-negative bacterial infections in a subject |
| 07/29/2003 | US6599745 Method to isolate mutants and to clone the complementing gene |
| 07/29/2003 | US6599735 Apparatus for use in the culturing of cells and generation of heterologous proteins |
| 07/29/2003 | US6599732 Regulation of carbon assimilation |
| 07/29/2003 | US6599731 Proteases from gram positive organisms |
| 07/29/2003 | US6599730 Subtilisin for use in cleaning hard surfaces |
| 07/29/2003 | US6599729 Agarase for use in the generation of preferential oligiosaccharide derivatives |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599726 Compositions and methods comprising cytostatic protein kinase |
| 07/29/2003 | US6599725 Polypeptide compositions for controlling cell death and disease resistance in plants |
| 07/29/2003 | US6599723 Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
| 07/29/2003 | US6599722 Method for producing ascorbic acid intermediates |
| 07/29/2003 | US6599714 Method of growing and analyzing a biofilm |
| 07/29/2003 | US6599709 Method for screening for soluble ligands to a receptor-type tyrosine kinase |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599700 Methods for detection of transition single-nucleotide polymorphisms |
| 07/29/2003 | US6599507 Composition for the treatment of immune deficiencies and methods for its preparation and use |
| 07/29/2003 | CA2179014C Method for inducing dna synthesis in neurons |
| 07/29/2003 | CA2146965C Cyclin complex rearrangement and uses related thereto |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/29/2003 | CA2093664C Modified ribozymes |
| 07/29/2003 | CA2082802C Method for expressing polypeptides in cyanobacteria |
| 07/29/2003 | CA2053586C Defined culture medium for cho cells |
| 07/24/2003 | WO2003060765A1 Method of constructing stereostructure of protein having plural number of chains |
| 07/24/2003 | WO2003060478A2 Methods and compositions for assaying homocysteine |
| 07/24/2003 | WO2003060476A2 Modulation of cop9 signalsome isopeptidase activity |
| 07/24/2003 | WO2003060153A2 Irak-m is a negative regulator of toll-like receptor signaling |
| 07/24/2003 | WO2003060152A2 Alteration of restriction endonuclease specificity by genetic selection |
| 07/24/2003 | WO2003060144A2 High fidelity dna polymerase compositions and uses therefor |
| 07/24/2003 | WO2003060136A2 D-galacturonate reductase of fragaria ananassa and its use in methods for increasing production of vitamin c in plants |
| 07/24/2003 | WO2003060132A1 Novel phospholipase a2 and gene thereof |
| 07/24/2003 | WO2003060131A1 SUGAR TRANSFERASE GnT-V HAVING ANGIOGENIC EFFECT |
| 07/24/2003 | WO2003060130A2 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 07/24/2003 | WO2003060129A1 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 07/24/2003 | WO2003060128A2 Compositions, methods and systems for discovery of lipopeptides |
| 07/24/2003 | WO2003060127A2 Genes and proteins involved in the biosynthesis of lipopeptides |
| 07/24/2003 | WO2003060124A1 NOVEL PROTEINS PARTICIPATING IN STRESS RESPONSE VIA THE ACTIVATION OF p38 MAPK AND GENES THEREOF |
| 07/24/2003 | WO2003060112A1 Lipolytic enzyme variants and method for their production |
| 07/24/2003 | WO2003060110A2 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 07/24/2003 | WO2003060109A2 Human subtilisin/kexin-like convertase |
| 07/24/2003 | WO2003060102A2 Crystal structures of jnk-inhibitor complexes and binding pockets thereof |
| 07/24/2003 | WO2003060100A2 CRYSTALLIZED DnaG PRIMASE COMPLEXES AND METHODS OF USE THEREOF |
| 07/24/2003 | WO2003060094A2 Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of the epimers |
| 07/24/2003 | WO2003060092A2 Modified fatty acid hydroxylase protein and genes |
| 07/24/2003 | WO2003060081A2 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003060079A2 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof |
| 07/24/2003 | WO2003060067A2 P85-alpha nucleic acids, polypeptides and related methods |
| 07/24/2003 | WO2003060063A2 Hyaluronan synthase genes and expression thereof |
| 07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | WO2003059945A2 Soluble recombinant protein production |
| 07/24/2003 | WO2003059938A1 Chromatin remodeling protein as a marker expressed by stromal progenitor cells |
| 07/24/2003 | WO2003059268A2 A novel germ cell-specific contraceptive target |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | WO2003059086A1 Granulates containing feed-enzymes |
| 07/24/2003 | WO2003022032A3 Method for increasing stress tolerance in plants |
| 07/24/2003 | WO2003020924A3 Stable storage of proteins |
| 07/24/2003 | WO2003006651A3 Vascular tissue preferred promoters |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2003004669A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression |
| 07/24/2003 | WO2003004663A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 07/24/2003 | WO2002090531A3 Peptidylarginine deiminase 6 |
| 07/24/2003 | WO2002079223A3 Covalently reactive transition state analogs and methods of use thereof |